Combined long term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response HIV vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in…
Active Awarded Last action
- Contract number
- HT942525FE074
- Awardee
-
Laulima Government Solutions, LLC UEI QTJZT9K41S61
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,169,926
Award facts
- Contract value 100% obligated
- $1,169,925.80 Current and potential, with all options
- Completion date 54% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20910, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,169,926 |
About this award
The Defense Health Agency issued a $1,169,925.80 delivery order to Laulima Government Solutions, LLC on September 30, 2025, under a total small business set-aside, for a combined long-term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response HIV vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in support of the war fighter.
Laulima is a Native Hawaiian Organization-owned, SBA Certified 8(a) small disadvantaged business. Place of performance is Silver Spring, Maryland. The order carries a cost-plus-fixed-fee pricing structure with an ultimate completion date of September 29, 2027.
Description
Combined long term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response HIV vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in support of the war fighter.
Quick answers
Who was awarded contract HT942525FE074?
HT942525FE074 was awarded to Laulima Government Solutions, LLC by Defense Health Agency (Department of Defense) on September 30, 2025.
How much is contract HT942525FE074 worth?
The government has obligated $1,169,926 on HT942525FE074.
Is contract HT942525FE074 an order under another contract?
Yes. HT942525FE074 is a delivery order under W81XWH19D0011, an indefinite delivery contract.
Was contract HT942525FE074 competed?
The extent of competition for HT942525FE074 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award